Related Experiment Video
Updated: Jul 23, 2025

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
Published on: June 6, 2025
PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection.
Dijin Xu1,2,3,4, Weiqian Jiang1,2,3, Lizhen Wu3
1Howard Hughes Medical Institute, New Haven, CT, USA.
Phospholipid scramblase 1 (PLSCR1) acts as a cell-autonomous defense against SARS-CoV-2, including variants like Delta and Omicron. This protein blocks viral entry by targeting vesicles and preventing fusion, offering a new target for antiviral strategies.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Understanding protective immunity against SARS-CoV-2 is vital for pandemic preparedness and combating variants.
- While neutralizing antibodies are studied, local cell-autonomous defense mechanisms are also crucial.
- Previous research highlights the importance of host cell factors in controlling viral infections.
Purpose of the Study:
- To identify host cell factors involved in cell-autonomous defense against SARS-CoV-2.
- To investigate the role of phospholipid scramblase 1 (PLSCR1) in restricting SARS-CoV-2 infection.
- To elucidate the mechanism by which PLSCR1 inhibits viral entry.
Main Methods:
- Genome-wide CRISPR-Cas9 screens in human lung epithelia and hepatocytes.
- Interferon-gamma (IFNγ) stimulation to induce PLSCR1 expression.
- Infection assays with live SARS-CoV-2 (USA-WA1/2020, Delta, Omicron BA.1) and other coronaviruses.
- 4Pi single-molecule switching nanoscopy and bipartite nano-reporter assays.
- Functional conservation studies in bats and mice.
Main Results:
- PLSCR1 was identified as a potent cell-autonomous restriction factor against SARS-CoV-2.
- IFNγ-induced PLSCR1 restricted multiple SARS-CoV-2 lineages and other pathogenic coronaviruses.
- PLSCR1 interfered with both endocytic and TMPRSS2-dependent viral entry routes.
- PLSCR1 directly targeted viral vesicles, preventing spike-mediated fusion and viral escape.
- A C-terminal β-barrel domain of PLSCR1, not its lipid scramblase activity, was essential for blocking fusion.
Conclusions:
- PLSCR1 is a critical host defense protein that inhibits SARS-CoV-2 at a late stage of viral entry.
- PLSCR1's mechanism involves preventing fusion of viral vesicles with host cell membranes.
- PLSCR1 represents a potential therapeutic target for developing novel anti-coronavirus strategies.
- Understanding PLSCR1 function is important, especially considering COVID-associated mutations in susceptible individuals.
More Related Videos
05:23Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
Related Concept Videos
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Leaky Scanning
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Regulation of Nuclear Protein Sorting